2015 American Transplant Congress
Regional Mismatch Between Liver Supply and Demand: An Argument for a More Open Market
Background: Geographic disparities in liver transplantation (LT) are well recognized. But the degree to which regional variation in deceased donor deficits contributes to wait-list mortality…2015 American Transplant Congress
Long-Term Outcome of Liver Transplant Recipients (OLT) With Hepatitis C Recurrence (HCVR) Who Achieved Postoperative Sustained Virologic Response (SVR) After Combination Antiviral Therapy (Rx) With and Without the Use of Telaprevir (TVR): A Single Center Experience
Liver Institute, Methodist Dallas Medical Center, Dallas, TX.
Aim: Liver allografts of viremic OLT have a higher risk of failure. Timely intervention is necessary. However, long-term outcome reports, especially using newer agents, is…2015 American Transplant Congress
The Effects of Change in Body Mass Index on Morbidity and Mortality After Liver Transplantation
AIM: Typically, a large BMI (body mass index) is associated with poor health as it can lead to a variety of diseases; we investigate frequency…2015 American Transplant Congress
Intraoperative Renal Replacement Therapy During Liver and Liver-Kidney Transplant: Outcomes of 155 Cases
1Transplantation, Mayo Clinic, Jacksonville, FL; 2Florida State University, Tallahassee, FL.
Background: Renal dysfunction in liver (LT) and liver-kidney (LKT) transplant candidates increases intraoperative risks of electrolyte disturbances and volume excess complications. The role of intraoperative…2015 American Transplant Congress
Validation of the Early Postoperative labMELD as Predictor of Outcome After Transplantation of Extended Criteria Donor Livers
Background:Since there is no generally accepted standard definition of early allograft dysfunction (EAD) after liver transplantation, we recently suggested postoperative labMELD as predictor for outcome…2015 American Transplant Congress
Outcomes of Living and Deceased Donor Liver Transplant Recipients According to the MELD Score
Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea.
BackgroundLiving donor liver transplantation (LDLT) has developed as an alternative to decease donor liver transplantation (DDLT) to overcome the critical shortage of deceased organ donations.…2015 American Transplant Congress
Pilot Study on Safety and Feasibility of Complete Meal Replacement in Liver Transplant Recipients and Potential Donors
Background: Metabolic syndrome (MS) and hepatic steatosis (HS) are potential long-term complications after liver transplantation (LT). Post-LT caloric intake normalizes which can result in obesity.…2015 American Transplant Congress
Outcomes of Patients With Hepatocellular Carcinoma Receiving a Donation After Cardiac Death Liver Graft
Background: Recent data suggests that patients with Hepatocellular carcinoma (HCC) who receive a donation after cardiac death (DCD) graft have inferior graft and patient survival…2015 American Transplant Congress
Arterial Blood Pressure at Time of Liver Transplant (LT) Evaluation Correlates With Kidney Biopsy Findings in LT Candidates With Renal Dysfunction
Transplant, Mayo Clinic, Jacksonville, FL.
Renal dysfunction is common in LT candidates; however, predicting post-LT renal recovery is sometimes difficult. Kidney biopsy is helpful in identifying reversible renal injury but…2015 American Transplant Congress
The Significant Association Between the Functional Polymorphism (Rs3761548) of Foxp3 Gene and the Severity of Acute Cellular Rejection in Liver Transplantation
Department of Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan.
Aim- Acute cellular rejection (ACR) accounts for 15-25% of graft failure in living donor liver transplantation (LDLT). T regulatory cells (Treg) play an important role…
American Transplant Congress abstracts